ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 90 filers reported holding ATHIRA PHARMA INC in Q2 2021. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $59,504 | -27.4% | 20,171 | -38.4% | 0.00% | – |
| Q1 2023 | $81,925 | +88.5% | 32,770 | +139.0% | 0.00% | – |
| Q4 2022 | $43,464 | -48.9% | 13,711 | -52.1% | 0.00% | – |
| Q3 2022 | $85,000 | +77.1% | 28,623 | +81.8% | 0.00% | – |
| Q2 2022 | $48,000 | -80.2% | 15,746 | -12.3% | 0.00% | – |
| Q1 2022 | $242,000 | -6.9% | 17,962 | -10.1% | 0.00% | – |
| Q4 2021 | $260,000 | -28.0% | 19,987 | -48.1% | 0.00% | – |
| Q3 2021 | $361,000 | +53.0% | 38,480 | +67.1% | 0.00% | – |
| Q2 2021 | $236,000 | +50.3% | 23,031 | +169.0% | 0.00% | – |
| Q1 2021 | $157,000 | -49.2% | 8,561 | -5.0% | 0.00% | – |
| Q4 2020 | $309,000 | – | 9,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |